M. Tuttleman et al., ATTITUDES AND BEHAVIORS OF PRIMARY CARE PHYSICIANS REGARDING TIGHT CONTROL OF BLOOD-GLUCOSE IN IDDM PATIENTS, Diabetes care, 16(5), 1993, pp. 765-772
Citations number
38
Categorie Soggetti
Endocrynology & Metabolism","Medicine, General & Internal","Public, Environmental & Occupation Heath
OBJECTIVE - To evaluate attitudes and practices of primary-care physic
ians toward tight blood glucose control in IDDM. RESEARCH DESIGN AND M
ETHODS - A mail and telephone questionnaire survey was conducted on a
systematic, stratified sample of 1429 family-practice physicians, gene
ral practitioners, internists, and pediatricians in active practice in
the United States who treated patients with IDDM. Physicians were ask
ed about methods they used for clinical and laboratory assessment of b
lood glucose control and about their attitudes and beliefs in treating
IDDM. They were asked also what they consider to be acceptable ranges
for blood glucose and HbA1 in IDDM patients. A score was developed re
flecting three criteria for tight blood glucose control: fasting gluco
se 70-120 mg/dl (3.9-6.7 mM), 2-h postprandial glucose < 180 mg/dl (<
10 mM), and HbA1 less-than-or-equal-to 8% the nondiabetic value was sp
ecified as 5-7%). Physicians were accorded one point when their accept
able range agreed with an intensive treatment criterion (range for sco
re 0-3). RESULTS - Only 3 1% of physicians agreed with all three crite
ria for tight control of blood glucose; 37% agreed with none or only o
ne of the standards. Pediatricians were particularly low in their agre
ement with the HbA, standard. Physicians who agreed with one of the th
ree criteria often did not agree with the other two. With increasing v
alue for the score, there was a greater proportion of physicians whose
management practices (e.g., frequent measurement of HbA1, multiple in
sulin injections, patient SMBG, use of dietitian/educator in care of p
atients) are conducive toward tight control of blood glucose. However,
even among physicians with a score of 3, HbA, was ordered infrequentl
y, three or more insulin injections/day was prescribed rarely, patient
SMBG was less than fully endorsed, and both a dietitian and diabetes
educator were used by a minority of physicians. CONCLUSIONS - it appea
rs that primary-care physicians are not fully aware of recommended cri
teria for intensive treatment of blood glucose in IDDM patients or of
the importance of multiple insulin injections, use of HbA1, and patien
t SMBG. Physician practice behaviors are less than optimal for intensi
ve management of IDDM patients, even among physicians who agree with a
ll three standards for intensive treatment of blood glucose in IDDM.